Dharam J. Kumbhani, M.D., S.M.; Deepak L. Bhatt, M.D., F.A.C.C.; Anthony A. Bavry, M.D., M.P.H., F.A.C.C. Hypothesis: ESAs would be associated with a lower risk of ...
Citing patients' needs and unhappy with the US Food and Drug Administration placing a black box warning on Aranesp, as well as a government reimbursement decision that could threaten nearly $1 ...